Fig. 1. Overall survival for all 41 patients with anaplastic thyroid carcinoma. The 1-year, 2-year, and 3-year overall survival rates were 37.2%, 29.0%, and 18.1%, respectively.

Int J Thyroidol 2024;17:286-94 https://doi.org/10.11106/ijt.2024.17.2.286

© 2024 Int J Thyroidol